Search

everythinglearnresearchcommunity

for

Search:↓

Different scalp and hair disorders are more common in certain ethnic groups, with the most common being androgenetic alopecia, which is treated with medications like minoxidil and finasteride.

Children receive less than half of recommended health care, and routine hormonal testing for female-pattern hair loss is unnecessary without other androgen excess symptoms.

Selenzin Peptide Active can effectively treat hair loss in postmenopausal women.

Patterned hair loss in women is linked to hormonal imbalances and biochemical changes, and should be evaluated for underlying health issues.

Dermatologists prefer minoxidil for mild female hair loss and a combination of PRP and minoxidil for severe cases, with a need for universal treatment guidelines.

The study found that alopecia areata and hypothyroidism increase the risk of each other, but androgenetic alopecia and hypothyroidism do not.

Pattern baldness is likely caused by a dominant gene influenced by testosterone levels, making it more common in men.

Hormonal imbalances contribute to female hair loss, and trichoscopy is a useful diagnostic tool.

Nivolumab can cause hair loss as a rare side effect.

Trichodynia is a painful scalp condition not directly linked to the amount or type of hair loss and may involve psychological factors, with treatments showing mixed results.

Ethinylestradiol/chlormadinone acetate may be an effective and well-tolerated treatment for skin conditions caused by excess androgens.

The most effective way to diagnose non-scarring hair loss is by transverse sectioning, and some cases, particularly in males with inflammation around hair follicles, might be curable.

The conclusion is that three signs can help diagnose hair loss after it happens, potentially avoiding more invasive tests.

Hypothyroidism may cause certain types of hair loss.

Stress, nutritional issues, and chronic diseases can cause hair loss, and nail changes may signal internal diseases; treatment focuses on the underlying cause.

The refined wash test is a reliable way to measure daily hair loss and can tell the difference between different types of hair loss.

The document concludes that understanding hair follicle histology and the hair cycle is crucial for diagnosing alopecia.

New treatments for alopecia areata show promise, but more research is needed to confirm their effectiveness.

Women with acne and PCOS should be checked for insulin resistance and related symptoms.

Oxidative stress contributes to hair graying and loss as we age.

Early and personalized treatment for hair loss in young people is crucial to prevent permanent damage and should include psychological support.

Certain growth factors significantly affect hair loss in women with telogen effluvium.

Skin biopsies are recommended for confirming alopecia diagnosis due to variability in clinical assessments; the link between vitamin D levels and alopecia is unclear.

A new mutation in the Hairless gene causes hair loss in two Pakistani families.

Hair loss led to the diagnosis of Cushing's disease in a patient, showing that hair loss can be a sign of hormonal disorders.

Topical Minoxidil is effective for hair loss after COVID-19.

Polycystic ovary syndrome costs the U.S. over $4 billion a year, mainly from treating related health issues.

The French Endocrine Society suggests diagnosing PCOS with two of three signs, recommends lifestyle changes and clomiphene for treatment, and calls for more research on certain treatments and tests.

Losing 5-10% body weight can improve PCOS symptoms, letrozole is better than clomiphene for fertility, and managing weight and blood sugar is important to reduce pregnancy complications.